G. Guarnieri

Antibiotic-Induced Neutropenia in Pediatric Patients: New Insights From Pharmacoepidemiological Analyses and a Systematic Review

E. Clementi, V. Fabiano, G. Zuccotti, 2022, Frontiers in Pharmacology.

Herpes zoster and simplex reactivation following COVID-19 vaccination: new insights from a vaccine adverse event reporting system (VAERS) database analysis

E. Clementi, S. Radice, M. Pozzi, 2022, Expert review of vaccines.

On the potential of drug repurposing in dysphagia treatment: New insights from a real-world pharmacovigilance study and a systematic review

E. Clementi, M. Nobile, N. Pizzorni, 2023, Frontiers in Pharmacology.

The potential antidepressant effect of antidiabetic agents: New insights from a pharmacovigilance study based on data from the reporting system databases FAERS and VigiBase

E. Clementi, M. Nobile, S. Radice, 2023, Frontiers in Pharmacology.

Psychiatric and non-psychiatric drugs causing false-positive amphetamines urine test in psychiatric patients: a pharmacovigilance analysis using FAERS

E. Clementi, B. Dell’Osso, C. Carnovale, 2023, Expert review of clinical pharmacology.

Preliminary evidence on the safety profile of BNT162b2 (Comirnaty): new insights from data analysis in EudraVigilance and adverse reaction reports from an Italian health facility

E. Clementi, S. Radice, C. Carnovale, 2021, Human vaccines & immunotherapeutics.

Two Years of Active Pharmacovigilance Surveillance and Therapeutic Reconciliation in Frail Populations: The MEAP 3.0 Study

G. Crescioli, S. Radice, C. Rafaniello, 2023, Journal of clinical medicine.

Valproic acid and prolonged QT: highlights from the FDA Adverse Event Reporting System FAERS database

S. Radice, C. Carnovale, G. Mosini, 2022, Pharmadvances.